Hydrofiber® Technology

Hydrofiber® technology in Action®

 

Hydrofiber® Value

Home

 

Hydrofiber® Technology Aquacel Ag

Transforming wound care with AQUACEL® Ag dressing

Logo Aquacel Ag

AQUACEL® Ag dressing provides clinicians and patients with all the benefits of Hydrofiber® Technology PLUS the benefits of ionic silver, in a versatile dressing for use with moderately-to-highly exuding chronic and acute wounds.

AQUACEL® Ag dressing is indicated for the management of infected wounds and wounds at risk of infection.
 

Transforming wounds

  • Creates a moist wound environment to support healing
  • Provides excellent absorption and retention1
  • Helps protect peri-wound skin and reduce maceration2,3

Transforming wound bioburden

  • Provides on-demand antimicrobial activity within the dressing4
  • Provides broad-spectrum antimicrobial activity4, *
  • Provides rapid and sustained antimicrobial activity4, 5,*
  • Helps balance the inflammatory response6

* As demonstrated in vitro.

Transforming patient and caregiver experience

  • Minimizes pain during wear and at dressing removal7, 8
  • Excellent ease of application and removal 9
  • 7 day wear time
  • Up to 14 day antimicrobial activity5, †

† As demonstrated in vitro with simulated wound fluid.

Transforming outcomes

  • AQUACEL® Ag dressing, in a protocol of care, reduced average healing time and more patients healed or improved (p=0.058) compared to a calcium alginate dressing in patients with diabetic foot ulcers over 8 weeks10
    • A prospective, multi-centre study in 134 patients comparing AQUACEL® Ag dressing with a calcium alginate dressing in non-ischaemic diabetic foot ulcers

    This study was funded by ConvaTec Inc.

  • AQUACEL® Ag dressing, in a protocol of care, produced an overall mean reduction of 23.9% in wound area over 18 days, with a 32% reduction in leg ulcers infected at baseline11
    • A multi-center, open label, non-randomized pilot study in 15 leg ulcer subjects, with mean ulcer duration of 2.59 years

    This study was funded by ConvaTec Inc.

  • AQUACEL® Ag dressing, in a protocol of care, produced a reduction in wound size in 70% of patients with stalled or critically colonized wounds compared to baseline over 4 weeks2
    • A single-center, open-label case series of 30 patients with wounds that had stalled or had the signs and symptoms of critical colonization

    This study was funded by ConvaTec Inc.

  • In patients with partial thickness burns, AQUACEL® Ag dressing was associated with less pain and anxiety at dressing change, fewer dressing changes, less nursing time and fewer procedural medications when compared to treatment with silver sulfadiazine cream for up to 21 days12
    • A randomized prospective multi-center controlled study in 82 patients with burns, AQUACEL® Ag dressing was compared to standard treatment of silver sulfadiazine cream under gauze dressing, in a protocol of care, for up to 21 days

    This study was funded by ConvaTec Inc.
 
 

To see AQUACEL® Ag dressings in action, please take a moment to watch our video presentation from David Parsons PhD, ConvaTec's Associate Director of Anti-infectives Research & Development.

 

References [+]

  1. Waring MJ, Parsons D. Physicochemical characterisation of carboxy-methylated spun cellulose fibres. Biomaterials. 2001;22:903-912.
  2. Coutts P, Sibbald RG. The effect of a silver-containing Hydrofiber dressing on superficial wound bed and bacterial balance of chronic wounds. Int Wound J. 2005;2(4):348-356.
  3. Robinson BJ. The use of a Hydrofiber dressing in wound management. J. Wound Care. 2000;9(1):32-34.
  4. Jones SA, Bowler PG, Walker M, Parsons D. Controlling wound bioburden with a novel silver-containing Hydrofiber® dressing.Wound Repair Regen. 2004;12:288–294.
  5. Bowler PG, Jones SA, Walker M, Parsons D. Microbicidal properties of a silver-containing Hydrofiber dressing against a variety of burn wound pathogens. J.Burn Care Rehabil. 2004;25:192–196.
  6. Hoekstra MJ, Hermans MH, Richters CD, Dutrieux RP. A histological comparison of acute inflammatory responses with a Hydrofiber or tulle gauze dressing. J. Wound Care. 2002;11(3):113-117.
  7. Armstrong SH, Brown DA, Hill E, Ruckley CV. A randomized trial of a new Hydrofiber® dressing, Aquacel, and an alginate in the treatment of exuding leg ulcers. Presented at: 5th European Conference on Advances in Wound Management; November 21-24, 1995; Harrogate, UK.
  8. Kogan L, Moldavsky M, Szvalb S, Govrin-Yehudain J. Comparative study of Aquacel and Silverol treatment in burns.Ann Burns Fire Disasters. 2004;17(4):201-207.
  9. Jurczak F, Durge T, Johnstone A, Offori T, Vujovic Z, Hollander D et al.Randomised clinical trial of Hydrofiber® dressing with silver versus povidone-iodine gauze in the management of open surgical and traumatic wounds. Int Wound J. 2007;44:66-76.
  10. Jude EB, Apelqvist J, Sprault M, Martini J. Prospective randomised controlled study of Hydrofiber dressing containing ionic silver or calcium alginate dressings in non-ischaemic diabetic foot ulcers. Diabetic Medicine. 2007; 24:280-288.
  11. Vanscheidt W, Lazareth I, Routkovsky-Norval. Safety Evaluation of a New Ionic Silver Dressing in the Management of Chronic Ulcers. Wounds. 2003;15:371-378.
  12. Caruso DM, Foster KN, Blome-Eberwein SA, et al. Randomized clinical study of Hydrofiber dressing with silver or silver sulfadiazine in the management of partial thickness burns. J Burn Care Res. 2006 May-Jun;27(3):298-309.